Zobrazeno 1 - 10
of 463
pro vyhledávání: '"Chikako, Shimizu"'
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 773-778 (2024)
Introduction: Breast cancer is the second most common cause of central nervous system (CNS) metastases. It has been shown that the median time from breast cancer diagnosis to CNS metastasis is 30.9 months and that the overall median survival after me
Externí odkaz:
https://doaj.org/article/1da8424be8934f448fe1ff8bd2a1d887
Autor:
Luis Costa, Rakesh Kumar, Cynthia Villarreal-Garza, Saket Sinha, Sunil Saini, Jayanti Semwal, Vartika Saxsena, Vaishali Zamre, Chintamani Chintamani, Mukurdipi Ray, Chikako Shimizu, Lejla Hadzikadic Gusic, Masakazu Toi, Allan Lipton
Publikováno v:
Breast, Vol 73, Iss , Pp 103623- (2024)
Despite advances in breast cancer care, breast cancer in young women (BCYW) faces unique challenges, diagnostic delays, and limited awareness in many countries. Here, we discuss the challenges and consequences associated with the delayed diagnosis of
Externí odkaz:
https://doaj.org/article/fbe7ddde39ee443ea4883eaf74001fb2
Autor:
Shani Paluch-Shimon, Patrick Neven, Jens Huober, Irfan Cicin, Matthew P. Goetz, Chikako Shimizu, Chiun-Sheng Huang, Hans Joachim Lueck, Jane Beith, Eriko Tokunaga, Jessica Reyes Contreras, Rosane Oliveira de Sant’Ana, Ran Wei, Ashwin Shahir, Sarah C. Nabinger, Tammy Forrester, Stephen R. D. Johnston, Nadia Harbeck
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: Abemaciclib is the first and only cyclin-dependent kinases 4 and 6 inhibitor approved for adjuvant treatment of hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−), node-positive, and high-risk ear
Externí odkaz:
https://doaj.org/article/9dbf86693a4a460dbf6601907c6ba0ed
Autor:
Kenju Ando, Akihiko Shimomura, Ryo Nasu, Misao Nakanishi, Yukino Kawamura, Akira Hangaishi, Hajime Oishi, Chikako Shimizu
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 3, Pp 1847-1852 (2021)
Therapy-related myelodysplastic syndrome (tMDS) and acute myeloid leukemia (tAML) are lethal complications of chemotherapy. The incidence rates are expected to increase owing to improvements of cancer treatment. Early diagnosis of tMDS/AML is crucial
Externí odkaz:
https://doaj.org/article/063de9a2ba0c4d21b0378249d3adc995
Autor:
Ann H. Partridge, Samuel M. Niman, Monica Ruggeri, Fedro A. Peccatori, Hatem A. Azim, Jr., Marco Colleoni, Cristina Saura, Chikako Shimizu, Anna Barbro Sætersdal, Judith R. Kroep, Audrey Mailliez, Ellen Warner, Virginia F. Borges, Frédéric Amant, Andrea Gombos, Akemi Kataoka, Christine Rousset-Jablonski, Simona Borstnar, Junko Takei, Jeong Eon Lee, Janice M. Walshe, Manuel Ruíz Borrego, Halle CF. Moore, Christobel Saunders, Fatima Cardoso, Snezana Susnjar, Vesna Bjelic-Radisic, Karen L. Smith, Martine Piccart, Larissa A. Korde, Aron Goldhirsch, Richard D. Gelber, Olivia Pagani
Publikováno v:
Breast, Vol 59, Iss , Pp 327-338 (2021)
Background: Premenopausal women with early hormone-receptor positive (HR+) breast cancer receive 5–10 years of adjuvant endocrine therapy (ET) during which pregnancy is contraindicated and fertility may wane. The POSITIVE study investigates the imp
Externí odkaz:
https://doaj.org/article/e32b73f6538741fb915cc74aa4bb1fbe
Autor:
Tatsunori Shimoi, Jun Hashimoto, Kazuki Sudo, Akihiko Shimomura, Emi Noguchi, Chikako Shimizu, Mayu Yunokawa, Kan Yonemori, Hiroshi Yoshida, Masayuki Yoshida, Tomoyasu Kato, Takayuki Kinoshita, Takahiro Fukuda, Yasuhiro Fujiwara, Kenji Tamura
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background The V-Akt murine thymoma viral oncogene (AKT) 1 (E17K) is a subfamily of serine/threonine protein kinases that affects the survival, proliferation, and invasion of cancer cells. The clinicopathological features and frequencies in
Externí odkaz:
https://doaj.org/article/6f2d3c49c7f84fc3b87a18b490f5b186
Autor:
Kaito Mimura, Akihiko Shimomura, Tomoko Gota, Kenju Ando, Yukino Kawamura, Tomoko Taniyama, Hajime Oishi, Chikako Shimizu
Publikováno v:
Gynecologic Oncology Reports, Vol 44, Iss , Pp 101084- (2022)
Uterine endometrial cancer is one of the most common gynecological malignancies worldwide. With relatively few options for late-line therapies for advanced or relapsed endometrial cancer, the use of pretreated therapies may broaden the choice of trea
Externí odkaz:
https://doaj.org/article/29f77e4683db4d969b5d97c07be51ddd
Autor:
Naohiro Yonemoto, Chikako Shimizu, Akihiko Shimomura, Shinichiro Ueda, Hiroshi Ohtsu, Kazuhiro Sase, Sakiko Miyazaki
Publikováno v:
Open Heart, Vol 9, Iss 2 (2022)
Objective Adjuvant chemotherapy with trastuzumab improves the postoperative life expectancy of women with early-stage breast cancer. Although trastuzumab is reportedly cardiotoxic, quantification based on real-world evidence is lacking. Therefore, in
Externí odkaz:
https://doaj.org/article/084bf093b783416bae32610d3ee9f996
Autor:
Fumiya Sato, Akihiko Shimomura, Kanako Nakayama, Yukino Kawamura, Kazuki Hashimoto, Yuko Ishibashi, Chikako Shimizu, Dai Kitagawa
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 2, Pp 944-949 (2021)
Spina bifida (SB) is a congenital neural tube defect that often presents with neurological disability and decubitus ulcers. A 66-year-old woman with SB presented to our hospital with decubitus ulcers and was treated by a plastic surgeon. She was refe
Externí odkaz:
https://doaj.org/article/5d668c23463647139dcfa5de63deb79d
Autor:
Yumiko Shimanuki, Akihiko Shimomura, Chiaki Ogawa, Masato Komuro, Hiroyuki Terakado, Takahiro Nishimura, Chikako Shimizu
Publikováno v:
Global Health & Medicine; Aug2024, Vol. 6 Issue 4, p268-272, 5p